Biohaven Pharmaceutical Holding Co (BHVN) Superinvestor holders
15 of the superinvestors we track hold Biohaven Pharmaceutical Holding Co (BHVN) in their latest 13F filings, $175M in total.
Summary
The largest holder is David Shaw (D. E. Shaw & Co.), with $62M, 0.0% of the portfolio.
In their latest quarter: 7 added, 7 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| David Shaw D. E. Shaw & Co. |
Added | 4,190,195 | $62M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 4,150,616 | $62M | 0.0% | Q2 2026 |
| David Vogel Voloridge Investment Management |
Trimmed | 882,724 | $13M | 0.1% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 651,349 | $10M | 0.0% | Q2 2026 |
| Alex Denner Sarissa Capital Management |
Added | 582,312 | $9M | 4.9% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Added | 491,918 | $7M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 443,775 | $7M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 150,752 | $2M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 92,773 | $1M | 0.0% | Q2 2026 |
| Didric Cederholm Lion Point Capital |
Held | 51,700 | $769,296 | 3.7% | Q2 2026 |
| Peter Muller PDT Partners |
Trimmed | 42,100 | $626,448 | 0.0% | Q2 2026 |
| Ken Tropin Graham Capital Management |
Trimmed | 20,056 | $298,433 | 0.0% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
Trimmed | 16,066 | $239,062 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 13,609 | $181,000 | 0.0% | Q3 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 11,388 | $169,453 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 15 |
| Q1 2026 | 16 |
| Q4 2025 | 13 |
| Q3 2025 | 14 |
| Q2 2025 | 15 |
| Q1 2025 | 16 |
| Q4 2024 | 17 |
| Q3 2024 | 16 |
Questions about Biohaven Pharmaceutical Holding Co
Which superinvestors own Biohaven Pharmaceutical Holding Co?
15 of the superinvestors we track hold Biohaven Pharmaceutical Holding Co (BHVN) in their latest 13F filings, $175M in total. David Shaw, Cliff Asness, David Vogel, Paul Marshall, Alex Denner, Steve Cohen.
Who is the largest superinvestor holder of BHVN?
The largest holder is David Shaw (D. E. Shaw & Co.), with $62M, 0.0% of the portfolio.
From Biohaven Pharmaceutical Holding Co's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.